Grubisha MJ, Sun X, MacDonald ML, Garver M, Sun Z, Paris KA, Patel DS, DeGiosio RA, Lewis DA,
Yates NA, Camacho C, Homanics GE, Ding Y, Sweet RA. MAP2 is differentially phosphorylated in
schizophrenia, altering its function. Mol Psychiatry. 2021 Feb 1:10.1038/s41380-021-01034-z. doi:
10.1038/s41380-021-01034-z. Epub ahead of print. PMID: 33526823; PMCID: PMC8325721.
DeGiosio, R., Kelly, R. M., DeDionisio, A. M., Newman, J. T., Fish, K. N., Sampson, A. R., Sweet, R. A.
(2019). MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with
schizophrenia. npj Schizophrenia, 5(1), 1–9.
McKinney, B. C., MacDonald, M. L., Newman, J. T., Shelton, M. A., DeGiosio, R. A., Kelly, R. M., Sweet,
R. A. (2019). Density of small dendritic spines and microtubule-associated-protein-2 immunoreactivity in
the primary auditory cortex of subjects with schizophrenia. Neuropsychopharmacology, 44(6), 1055–1061.
https://doi.org/10.1038/s41386-019-0350-7